|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2500097238 |
|
最近更新日期: Date of Last Refreshed on: |
2025-02-14 16:33:56 |
|
注册时间: Date of Registration: |
2025-02-14 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
单肺通气期间氧合指数与术后肺部并发症的关联:一项前瞻性队列研究 |
|
Public title: |
Associations between oxygenation index during one-lung ventilation and postoperative pulmonary complications: a prospective cohort study |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
单肺通气期间氧合指数与术后肺部并发症的关联:一项前瞻性队列研究 |
|
Scientific title: |
Associations between oxygenation index during one-lung ventilation and postoperative pulmonary complications: a prospective cohort study |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
高杨 |
研究负责人: |
陈立建 |
|
Applicant: |
Yang Gao |
Study leader: |
Lijian Chen |
|
申请注册联系人电话: Applicant telephone: |
+86 180 5512 5627 |
研究负责人电话: Study leader's telephone: |
+86 139 6669 9467 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
1595908487@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
chenlijian77@126.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
安徽省合肥市蜀山区绩溪路218号 |
研究负责人通讯地址: |
安徽省合肥市蜀山区绩溪路218号 |
|
Applicant address: |
218 Jixi Road, Shushan District, Hefei, Anhui |
Study leader's address: |
218 Jixi Road, Shushan District, Hefei, Anhui |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
安徽医科大学第一附属医院 |
||
|
Applicant's institution: |
The First Affiliated Hospital of Anhui Medical University |
||
|
研究负责人所在单位: |
安徽医科大学第一附属医院 |
||
|
Affiliation of the Leader: |
The First Affiliated Hospital of Anhui Medical University |
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
PJ2024-12-42 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
安徽医科大学第一附属医院临床医学研究伦理委员会 |
||
|
Name of the ethic committee: |
Clinical Medical Research Ethics Committee of the First Affiliated Hospital of Anhui Medical University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2025-01-24 00:00:00 |
||
|
伦理委员会联系人: |
陈奕豪 |
||
|
Contact Name of the ethic committee: |
Yihao Chen |
||
|
伦理委员会联系地址: |
安徽省合肥市蜀山区绩溪路218号 |
||
|
Contact Address of the ethic committee: |
218 Jixi Road, Shushan District, Hefei, Anhui |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 551 6292 3102 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
安徽医科大学第一附属医院 |
||||||||||||||||||||||
|
Primary sponsor: |
The First Affiliated Hospital of Anhui Medical University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
安徽省合肥市蜀山区绩溪路218号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
218 Jixi Road, Shushan District, Hefei, Anhui |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
国家自然科学基金 |
||||||||||||||||||||||
|
Source(s) of funding: |
National Natural Science Foundation of China |
||||||||||||||||||||||
|
Target disease: |
Lung Surgery |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
连续入组 |
||||||||||||||||||||||
|
Study design: |
Sequential |
||||||||||||||||||||||
|
研究目的: |
1.观察单肺通气期间氧合指数与胸腔镜肺切除手术患者术后肺部并发症的关联; 2.描述单肺通气期间氧合指数的变化轨迹; 3.观察单肺通气期间氧合指数的变化轨迹与胸腔镜肺切除手术患者术后肺部并发症的关联。 |
||||||||||||||||||||||
|
Objectives of Study: |
To observe the association between oxygenation index during one-lung ventilation and postoperative pulmonary complications in patients undergoing lung surgery; To describe the trajectory of oxygenation index during one-lung ventilation; To observe the relationship between the trajectory of oxygenation index during one-lung ventilation and postoperative pulmonary complications in patients undergoing lung surgery. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1.拟择期在全麻下行胸腔镜下肺部分切除手术患者; 2.年龄>= 18岁,性别不限; 3.美国麻醉医师协会(American Society of Anesthesiologists, ASA)分级 I-IV级; 4.预计单肺通气持续时间>= 60分钟; 5.知晓、同意参与试验并签署书面知情同意书。 |
||||||||||||||||||||||
|
Inclusion criteria |
1.Patients undergoing thoracoscopic partial lung resection under general anesthesia; 2.Age >= 18 years old, gender unlimited; 3.American Society of Anesthesiologists (ASA) grades I-IV; 4.Expected one-lung ventilation duration >= 60 min; 5.Voluntary subjects signed informed consent. |
||||||||||||||||||||||
|
排除标准: |
1.严重肺部疾病,如慢性阻塞性肺疾病(GOLD 3 - 4级)、严重哮喘,胸廓及脊柱畸形、胸腔积液、气胸、既往肺部手术术史等影响肺部顺应性的疾病史; 2.严重心脏(NYHA III级或IV级)、肝脏(Child-Pugh 10 – 15分)、肾脏(肾替代治疗)、造血系统(白血病)疾病; 3.既往肺部手术史; 4.术前两周内上呼吸道感染病史; 5.近3个月参与其他临床研究. |
||||||||||||||||||||||
|
Exclusion criteria: |
1.Serious lung diseases, such as chronic obstructive pulmonary disease (GOLD grade 3-4), severe asthma, thoracic and spinal malformations, pleural effusion, pneumothorax, and history of prior lung surgery that affect lung compliance; 2.Severe heart (NYHA Grade III or IV), liver (Child-Pugh 10-15 points), kidney (renal replacement therapy), hematopoietic system (leukemia) diseases; 3.Previous history of lung surgery; 4.History of upper respiratory tract infection within 2 weeks before surgery; 5.Participating in other clinical studies in the past 3 months. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2025-03-01 00:00:00至 To 2027-03-01 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2025-03-01 00:00:00 至 To 2027-03-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
none |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
无 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
None |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
通过本实验的病例报告表收集数据,使用SPSS进行数据管理 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Data were collected through the case report form of the experiment, and SPSS was used for data management. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |